Standard BioTools EBITDA 2012-2025 | LAB
Standard BioTools ebitda from 2012 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
Standard BioTools Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-166 |
| 2023 | $-63 |
| 2022 | $-102 |
| 2021 | $-51 |
| 2020 | $-33 |
| 2019 | $-34 |
| 2018 | $-23 |
| 2017 | $-39 |
| 2016 | $-55 |
| 2015 | $-34 |
| 2014 | $-38 |
| 2013 | $-16 |
| 2012 | $-16 |
| 2011 | $-17 |
|
Standard BioTools Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $-32 |
| 2025-06-30 | $-22 |
| 2025-03-31 | $-30 |
| 2024-12-31 | $-55 |
| 2024-09-30 | $-25 |
| 2024-06-30 | $-28 |
| 2024-03-31 | $-58 |
| 2023-12-31 | $-18 |
| 2023-09-30 | $-17 |
| 2023-06-30 | $-14 |
| 2023-03-31 | $-13 |
| 2022-12-31 | $-19 |
| 2022-09-30 | $-25 |
| 2022-06-30 | $-35 |
| 2022-03-31 | $-23 |
| 2021-12-31 | $-7 |
| 2021-09-30 | $-16 |
| 2021-06-30 | $-13 |
| 2021-03-31 | $-15 |
| 2020-12-31 | $-13 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-9 |
| 2020-03-31 | $-10 |
| 2019-12-31 | $-5 |
| 2019-09-30 | $-10 |
| 2019-06-30 | $-11 |
| 2019-03-31 | $-8 |
| 2018-12-31 | $-4 |
| 2018-09-30 | $-5 |
| 2018-06-30 | $-6 |
| 2018-03-31 | $-7 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-11 |
| 2017-06-30 | $-12 |
| 2017-03-31 | $-13 |
| 2016-12-31 | $-13 |
| 2016-09-30 | $-14 |
| 2016-06-30 | $-14 |
| 2016-03-31 | $-15 |
| 2015-12-31 | $-10 |
| 2015-09-30 | $-4 |
| 2015-06-30 | $-10 |
| 2015-03-31 | $-10 |
| 2014-12-31 | $-6 |
| 2014-09-30 | $-9 |
| 2014-06-30 | $-9 |
| 2014-03-31 | $-14 |
| 2013-12-31 | $-4 |
| 2013-09-30 | $-4 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-4 |
| 2012-12-31 | $-3 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-4 |
| 2012-03-31 | $-6 |
| 2011-12-31 | $-2 |
| 2011-09-30 | $-4 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.596B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.493B | 42.21 |
| Tempus AI (TEM) | United States | $11.621B | 0.00 |
| Doximity (DOCS) | United States | $7.649B | 31.50 |
| Hims & Hers Health (HIMS) | United States | $6.743B | 54.85 |
| IRhythm Holdings (IRTC) | United States | $5.166B | 0.00 |
| Hinge Health (HNGE) | United States | $3.350B | 0.00 |
| Privia Health (PRVA) | United States | $2.945B | 184.15 |
| 10x Genomics (TXG) | United States | $2.832B | 0.00 |
| Heartflow (HTFL) | United States | $2.739B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.307B | 38.17 |
| Omnicell (OMCL) | United States | $2.257B | 46.15 |
| Azenta (AZTA) | United States | $1.842B | 75.57 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Enovis (ENOV) | United States | $1.316B | 6.91 |
| Schrodinger (SDGR) | United States | $1.210B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.139B | 0.00 |
| Phreesia (PHR) | United States | $0.955B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.860B | 0.00 |
| Talkspace (TALK) | United States | $0.671B | 135.00 |
| Claritev (CTEV) | United States | $0.477B | 0.00 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.362B | 0.00 |
| Carlsmed (CARL) | United States | $0.352B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.318B | 0.00 |
| TruBridge (TBRG) | United States | $0.309B | 14.22 |
| Senseonics Holdings (SENS) | United States | $0.299B | 0.00 |
| CapsoVision (CV) | United States | $0.281B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.260B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.179B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.160B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.159B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.093B | 0.00 |
| American Well (AMWL) | United States | $0.080B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.076B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.062B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.059B | 0.00 |
| 111 (YI) | China | $0.044B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| Movano (MOVE) | United States | $0.014B | 0.00 |
| Zhongchao (ZCMD) | China | $0.011B | 0.00 |
| HeartSciences (HSCS) | United States | $0.011B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |